LOW-VOLUME · SEX-BALANCED
tazarotene Side Effects
tazarotene (also sold as Tazorac) is a LOW-VOLUME FAERS extract #486 of 524 by FAERS report count. Still opens on SEX-BALANCED: 69% of sex-coded reports are female (681 F / 306 M).
Data updated 2026-05-15
- 1,132
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
tazarotene reporting skew - 69% of sex-coded reports are female (681 F / 306 M). Volume band LOW-VOLUME #486 of 524 by FAERS report count; caseload SIGNAL.
Thinner FAERS extract for tazarotene (Tazorac) (1,132 reports #486 of 524 by FAERS report count). 69% of sex-coded reports are female (681 F / 306 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ERYTHEMA leads 82 of 1,132 reports
Who reports · age peak 18-44 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 18-44 (227 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 15 reports (1.3% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| DEATH | 6 |
| COVID-19 | 4 |
| ILLNESS | 4 |
| IMMUNOSUPPRESSION | 4 |
| LUNG DISORDER | 4 |
| PNEUMOCYSTIS JIROVECII INFECTION | 4 |
| SKIN INFECTION | 4 |
| DRUG EXPOSURE DURING PREGNANCY | 2 |
| PREGNANCY | 2 |
| ABORTION SPONTANEOUS | 1 |
| ACUTE RESPIRATORY FAILURE | 1 |
| AFFECT LABILITY | 1 |
| AMMONIA INCREASED | 1 |
| ANENCEPHALY | 1 |
| ASTHENIA | 1 |
| BLOOD CHOLESTEROL INCREASED | 1 |
| BLOOD TRIGLYCERIDES INCREASED | 1 |
| CAESAREAN SECTION | 1 |
| CHRONIC HEPATIC FAILURE | 1 |
Reactions in Hospitalization Reports
Hospitalization mid-share (159, 14.0%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| DIARRHOEA | 14 |
| PAIN | 14 |
| ANXIETY | 12 |
| INFLAMMATORY BOWEL DISEASE | 11 |
| PULMONARY EMBOLISM | 11 |
| EMOTIONAL DISTRESS | 10 |
| INJURY | 10 |
| HEADACHE | 9 |
| HYPERTRANSAMINASAEMIA | 9 |
| COLITIS ULCERATIVE | 8 |
| DYSPNOEA | 8 |
| FATIGUE | 8 |
| PNEUMONIA | 8 |
| VOMITING | 8 |
| ABDOMINAL PAIN | 7 |
| ANAL HAEMORRHAGE | 7 |
| DEEP VEIN THROMBOSIS | 7 |
| DRUG EXPOSURE DURING PREGNANCY | 7 |
| DRY SKIN | 7 |
How to read tazarotene FAERS figures (SIGNAL · DEATH-MARKED · HOSP-MID)
FAERS holds 1,132 voluntary reports linked to tazarotene (Tazorac), 2004-2025. Death is listed on 15 (1.3%). Hospitalization appears on 159 (14.0%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with tazarotene
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 1,152 FAERS cases (Δ 20 heavier vs tazarotene); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 1,076 FAERS cases (Δ 56 lighter vs tazarotene); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 1,191 FAERS cases (Δ 59 heavier vs tazarotene); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 1,205 FAERS cases (Δ 73 heavier vs tazarotene); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 60.8 pp vs tazarotene's DEATH-MARKED): CASELOAD · HOSP-MID.
tazarotene stamps SIGNAL · SEX-BALANCED; class peers and methodology beat restating the same FAERS caveats on every effects URL.